GlassScriptPhysician profile
Heidi L Johnson
NPI 1578557443
$1,676.21
in general payments reported to CMS, 2019-2025
11 companies · $292 in 2025
The $292 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $198 · 2020: $147 · 2021: $183 · 2022: $306 · 2023: $375 · 2024: $173 · 2025: $292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $841.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $840.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $957.50 | 2019-2025 | Precision7, Total30, Precision 7 |
| Johnson & Johnson Vision Care, INC. | $289.87 | 2019-2024 | Acuvue |
| Allergan, INC. | $130.57 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $115.59 | 2023 | Ultomiris |
| Lkc Technologies, INC. | $64.42 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $38.70 | 2019-2020 | |
| Spark Therapeutics, INC. | $20.96 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $17.37 | 2024 | Xdemvy |
| Shire North American Group INC | $14.21 | 2019 | |
| Abbvie INC. | $13.72 | 2023 | |
| Coopervision INC. | $13.30 | 2023 | Clariti Contact Lens |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.